Log in
Home
Data and Resources
Biomarkers
Data
Informatics
Protocols
Publications
Specimen Reference Sets
Standard Operating Procedures
Statistical Resources
EDRN Common Data Elements (CDEs)
Data Sharing Policies
Work with EDRN
Advocacy Groups
Associate Membership Program
Funding Opportunities
Member Finder
Propose a Validation Study
Public-Private Partnerships
Memoranda of Understanding
News and Events
EDRN Newsletter
Upcoming Meetings
Meeting Reports
Webinars
About EDRN
Mission and Structure
FDA-Approved Tests
CLIA-Approved Markers
Five-Phase Approach and Prospective specimen collection, Retrospective Blinded Evaluation Study Design
Informatics and Data Science
History of the EDRN
Bookshelf
Sites
Committees and Collaborative Groups
Search
Search
EDRN
Data and Resources
Publications
Evaluating a New Cancer Screening Blood Test: Unintended Consequences and the Need for Clarity in Policy Making.
Evaluating a New Cancer Screening Blood Test: Unintended Consequences and the Need for Clarity in Policy Making.
Abstract
No abstract available.
Authors
Ransohoff DF
PubMed ID
32761203
Appears In
J Natl Cancer Inst, 2021, 113 (2)
